A phase 1 dose escalation study of CMD-193 in subjects with advanced malignant tumors.
Phase of Trial: Phase I
Latest Information Update: 15 Sep 2009
At a glance
- Drugs CMD 193 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 15 Sep 2009 Actual end date (Jul 2007) and actual number of patients (54) added as reported by ClinicalTrials.gov.
- 15 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.